Baseline characteristics of study population according to SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery trial (SYNTAX) Scores
| Variables | SYNTAX group 1 (n:169) | SYNTAX group 2 (n:156) | P value |
| Age (years) | 60.2±11.7 | 63.5±10.3 | 0.006 |
| Gender (n, %) (male) | 97, %57.4 | 76, %48.7 | 0.12 |
| DM (n, %) | 56, %33.1 | 86, %55.1 | 0.001 |
| HT (n, %) | 77, %45.6 | 81, %51.9 | 0.025 |
| HL (n, %) | 43, %25.4 | 60, %38.5 | 0.001 |
| Systolic blood pressure (mm Hg) | 134.1±23.2 | 134.3±19.3 | 0.96 |
| Diastolic blood pressure (mm Hg) | 75.2±13.1 | 74.2±12.2 | 0.46 |
| Heart rate (beat/min) | 73.5±16.7 | 77.3±16.3 | 0.04 |
| Smoking (n, %) | 74, %43.8 | 84, %53.8 | 0.07 |
| Glucose (mg/dL) | 121.5±53.9 | 134.9±54.6 | 0.03 |
| CR (mg/dL) | 0.88±0.27 | 0.89±0.34 | 0.92 |
| Ure (mg/dL) | 36.6±14.6 | 39.9±19.6 | 0.08 |
| Total cholestrol (mg/dL) | 189.9±43.8 | 194.9±52.7 | 0.34 |
| Trigliseride (mg/dL) | 153.3±87.06 | 132.5±87 | 0.55 |
| LDL (mg/dL) | 119.1±38.3 | 122.2±42.8 | 0.49 |
| White blood cell | 8.41±3.13 | 8.57±2.36 | 0.63 |
| Haemoglobin (g/dL) | 13.3±1.76 | 12.5±1.1 | 0.001 |
| Platelet | 246.8±94.6 | 260.3±92.6 | 0.24 |
| EF % | 56.0±6.7 | 55.3±6.8 | 0.35 |
| Height (cm) | 168.3±7.9 | 164.6±8.8 | 0.001 |
| Weight (kg) | 81.7±14.3 | 81.5±13.7 | 0.91 |
| Waist (cm) | 97.0±12.0 | 98.8±13.2 | 0.19 |
| Hip (cm) | 96.2±12.7 | 101.7±12.7 | 0.001 |
| BMI | 29.1±5.4 | 30.1±5.1 | 0.09 |
| BFP | 36.9±6.4 | 38.5±6.9 | 0.02 |
| BFM | 30.9±9.2 | 32.0±9.3 | 0.32 |
| RFM | 31.2±6.8 | 36.2±7.9 | 0.001 |
BFM, body fat mass; BFP, body fat percentage; BMI, body mass index; CR, creatinine; DM, diabetes mellitus; EF, ejection fraction; HL, hyperlipidaemia; HT, hypertension; LDL, low-density lipoprotein; RFM, relative fat mass.